Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Add To Watchlist

TSX:AEZS - Post Discussion

COSCIENS Biopharma Inc > Re: Oct 8

View:

Post by Hopeforthebest on Jul 25, 2024 8:45am

Re: Oct 8

Hey proph that they will finally announce to commissioning of the PGX 50 scale is finally completed, after all it has been almost 8 months after the promised completion date and in true gagnon fashion failure and delays and lies

106

Comment

Comment by prophetoffactz on Jul 25, 2024 9:27am

Commissioning of the 50L facility happened on schedule by the end of Q1 2024 and entered the fine tuning phase with three production runs as of April. Additionally, they delighted with the announcement that the product(PGX-YBG) could be available by year-end pending Health Canada approval. The 100L facility is expected to be commissioned this quarter with industry leader Natex and is the decision ...more

Comment

COSCIENS Biopharma Inc